Skip to main content

Predictive values of clinical parameters for severe Japanese spotted fever

Abstract

Japanese spotted fever (JSF) is severe and can progress to disseminated intravascular coagulation (DIC) with a poor prognosis. We considered whether patient factors are related to serious complications. Between August 1999 and March 2009, all patients with JSF and retrievable clinical data (age, gender, length of hospital stay, medication, comorbidities), vital signs (blood pressure, heart rate, temperature), and laboratory test results [blood cell count, liver function, renal function, electrolytes, blood sugar, C-reactive protein (CRP), CRP normalization period, and aspartate aminotransferase normalization period] from the Integrated Intelligent Management System (IIMS) database, were retrospectively analyzed by logistic regression. There were 51 JSF patients (24 men, 27 women) with a mean age of 63.0 years. Six patients (11.8%) had DIC, but there were no in-hospital deaths. The time between fever onset and initiation of medication was approximately 5 days, but this delay was not associated with disease severity. We identified values correlating with disease severity (p < 0.1) by univariate analysis and then applied logistic regression. We found renal dysfunction [serum creatinine (Cr) ≥1.5 mg/dl] at the time of initial presentation to be predictive of DIC. Cr was also predictive of a prolonged disease course. In patients with JSF, renal function must be carefully monitored when determining clinical management.

This is a preview of subscription content, access via your institution.

References

  1. Mahara F, Koga K, Sawada S, et al. The first report of the rickettsial infections of spotted fever group in Japan: three clinical cases. Kansenshogaku Zasshi. 1985;59:1165.

    PubMed  CAS  Google Scholar 

  2. Mahara F. Japanese spotted fever: report of 31 cases, review of the literature. Emerg Infect Dis. 1997;3:105.

    PubMed  Article  CAS  Google Scholar 

  3. Masters EJ, Olson GS, Weiner SJ, Paddock CD. Rocky Mountain spotted fever: a clinician’s dilemma. Arch Intern Med. 2003;163(7):769–74.

    PubMed  Article  Google Scholar 

  4. Takagaki K. Rickettsia infections. Nihonhihukagaku Zasshi. 2006;116:2247.

    Google Scholar 

  5. Conlon PJ, Procop GW, Fowler V, Eloubeidi MA, Smith SR, Sexton DJ. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med. 1996;101:621–6.

    PubMed  Article  CAS  Google Scholar 

  6. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001;184(11):1437–44.

    PubMed  Article  CAS  Google Scholar 

  7. Tahara K, Hoshina K, Itagaki T, et al. Incidence and epidemiology of rickettsial diseases in the Chugoku and Shikoku region. Ministry of Health research grants, Emerging and Reemerging Infectious Diseases Research Project: Early warning systems for early diagnosis and establishment of a national survey of rickettsial infections; 2008. p. 87–98.

  8. Wada K, Sakaeda H, Aono R, Chiya S. Fulminant Japanese spotted fever—the second fatal case in Japan. J Jpn Assoc Infect Dis. 2008;82:77–81.

    Google Scholar 

  9. Kodama K, Senba T, Yamauchi H, Nomura T, Chikahira Y. Clinical study of Japanese spotted fever and its aggravating factors. J Infect Chemother. 2003;9:83–7.

    PubMed  Article  Google Scholar 

  10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Crit Care Med. 1992;20(6):864–74.

    Article  Google Scholar 

  11. Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, Jacobs RF, Tick-borne Infections in Children Study Group. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007;150:180–4.

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The authors appreciate the Shimane Prefectural Institute of Public Health and Environment Science for diagnosing JSF using indirect fluorescent antibody tests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsukasa Nakamura.

About this article

Cite this article

Nakamura, T., Takagaki, K., Matsubara, Y. et al. Predictive values of clinical parameters for severe Japanese spotted fever. J Infect Chemother 17, 246–253 (2011). https://doi.org/10.1007/s10156-010-0113-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-010-0113-1

Keywords

  • Japanese spotted fever
  • DIC